Core Viewpoint - Sichuan Jinjiang Electronic Medical Equipment Technology Co., Ltd. has submitted an IPO guidance filing to the securities regulatory authority, marking its second attempt at an IPO within three years [1] Group 1: IPO Attempts - Jinjiang Electronic previously attempted to launch an IPO on the Sci-Tech Innovation Board in June 2023 but withdrew its application after just one round of inquiries, leading to the termination of the IPO review [2] - The underwriting institution for both of Jinjiang Electronic's IPO attempts has been CITIC Securities [2] Group 2: Disclosure Inconsistencies - CITIC Securities noted in the IPO guidance materials that Jinjiang Electronic has not had any IPO applications terminated, which contradicts the company's recent history of withdrawing its application [5] - In contrast, another company, Aike Medical, which also attempted an IPO twice, had detailed disclosures regarding its previous application withdrawal and termination, raising questions about the consistency of disclosures by CITIC Securities [4][5] Group 3: Product Focus and Market Competition - Jinjiang Electronic focuses on electrophysiological three-dimensional mapping systems, catheters, radiofrequency ablation, and various consumables, with its most innovative product being the Pulsed Field Ablation (PFA) system, which is expected to receive approval from the National Medical Products Administration in 2024 [5] - The PFA system represents a significant advancement over existing ablation techniques, offering advantages such as shorter treatment times and reduced risk of complications [6] - However, the PFA market is becoming increasingly competitive, with several domestic medical device companies, including Huitai Medical and Aike Mai, also receiving approvals for their PFA products by the end of 2024 [6][7]